uniQure Announces Company Presentations at Upcoming May Conferences
May 01, 2017 11:01 am UTC| Business
-- Investor breakfast event and webcast at ASGCT on Friday, May 12 at 7:00 a.m. EDT -- LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 01, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company...
May 01, 2017 11:01 am UTC| Business
Key updates At ARVO ProQR will present additional positive pre-clinical proof-of-concept (PoC) data for QR-110 targeting LCA 10. The company has recently received IND clearance to start clinical trials for this program...
May 01, 2017 11:01 am UTC| Business
Key updates At ARVO ProQR will present additional positive pre-clinical proof-of-concept (PoC) data for QR-110 targeting LCA 10. The company has recently received IND clearance to start clinical trials for this program...
May 01, 2017 11:01 am UTC| Business
DUBLIN, Ireland, May 01, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible...
May 01, 2017 11:01 am UTC| Business
DUBLIN, Ireland, May 01, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible...
PLx Pharma Appoints Michael J. Dillon as Vice President, Sales and Marketing
May 01, 2017 11:01 am UTC| Business
HOUSTON, May 01, 2017 -- PLx Pharma Inc.(NASDAQ:PLXP) (“PLx”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81 mg (referred to...
PLx Pharma Appoints Michael J. Dillon as Vice President, Sales and Marketing
May 01, 2017 11:01 am UTC| Business
HOUSTON, May 01, 2017 -- PLx Pharma Inc.(NASDAQ:PLXP) (“PLx”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 mg and Aspertec™ 81 mg (referred to...